Page last updated: 2024-08-23

alkenes and Idiopathic Parkinson Disease

alkenes has been researched along with Idiopathic Parkinson Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, Y; Cui, M; Fu, H; Li, Y; Liu, S; Liu, Y; Wan, R; Yan, XX; Yan, Y; Zeng, Q1
Feng, YB; Gong, JX; Huang, KX; Li, HB; Li, XK; Qu, J; Spencer, S; Tao, QF; Wang, F; Wu, XM; Wu, YH; Yang, LX; Zeng, S; Zhao, Y1

Other Studies

2 other study(ies) available for alkenes and Idiopathic Parkinson Disease

ArticleYear
D-π-A-Based Trisubstituted Alkenes as Environmentally Sensitive Fluorescent Probes to Detect Lewy Pathologies.
    Analytical chemistry, 2022, 11-08, Volume: 94, Issue:44

    Topics: Alkenes; alpha-Synuclein; Brain; Fluorescent Dyes; Humans; Parkinson Disease; Plaque, Amyloid

2022
Design, synthesis, and examination of neuron protective properties of alkenylated and amidated dehydro-silybin derivatives.
    Journal of medicinal chemistry, 2009, Dec-10, Volume: 52, Issue:23

    Topics: Alkenes; Alzheimer Disease; Amides; Animals; Drug Design; Free Radical Scavengers; Humans; Iron Chelating Agents; Lipid Peroxidation; Liver; Male; Models, Molecular; Molecular Conformation; Neurons; Neuroprotective Agents; Parkinson Disease; PC12 Cells; Rats; Silymarin; Structure-Activity Relationship; Xanthine Oxidase

2009